Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC38467 structure
    GC38467BTdCPU
    CAS: 1257423-87-2
    纯度: >99.00%

    BTdCPU是一种通过激活血红素调节抑制激酶(HRI)发挥作用的化合物,BTdCPU能够促进eIF2α的磷酸化,诱导细胞凋亡。

  • GC38545 structure
    GC38545Polygalacin D
    CAS: 66663-91-0
    纯度: >99.00%

    Polygalacin D (PGD) 是从桔梗 Platycodon grandiflorum 中分离的具有抗癌和抗增殖特性的生物活性化合物。Polygalacin D 抑制 IAP 蛋白家族的表达,包括存活蛋白,cIAP-1 和 cIAP-2 蛋白,并通过抑制 GSK3β,Akt 的磷酸化和PI3K 的表达来阻断 PI3K/Akt 途径。Polygalacin D 通过 PI3K/Akt 途径诱导凋亡 (apoptosis)。

  • GC38564 structure
    GC38564Deoxypodophyllotoxin
    CAS: 19186-35-7
    纯度: >99.50%

    A flavolignan with diverse biological activities

  • GC38566 structure
    GC38566Ilexsaponin A
    CAS: 108524-93-2

    Ilexsaponin A 是从冬凌草的根中分离出的,通过抗凋亡途径减轻缺血再灌注引起的心肌损伤。Ilexsaponin A 可以减少心肌梗塞的大小,降低 LDH,AST 和 CK-MB 的血清水平,增加细胞活力并抑制缺氧/复氧心肌细胞的凋亡。

  • GC38592 structure
    GC38592PTC596
    CAS: 1610964-64-1
    纯度: >98.00%

    A BMI1 inhibitor

  • GC38606 structure
    GC38606Glaucocalyxin A
    CAS: 79498-31-0
    纯度: >99.00%

    Glaucocalyxin A is a biologically active ent-kauranoid diterpenoid isolated from Rabdosia japonica var. glaucocalyx with antitumor and anti-inflammatory activity. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.

  • GC38609 structure
    GC38609Rotundic acid
    CAS: 20137-37-5
    纯度: >98.00%

    Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.RA induces cell cycle arrest, DNA damage, and apoptosis by modulating the AKT/mTOR and MAPK pathways.

  • GC38610 structure
    GC38610Galgravin
    CAS: 528-63-2

    A lignan with diverse biological activities

  • GC38617 structure
    GC38617Dihydrokaempferol
    CAS: 480-20-6
    纯度: >99.50% / >98.00% / >98.50%

    Dihydrokaempferol(Aromadendrin)是一种天然存在的黄酮类化合物,具有清除自由基、抗炎、抗肿瘤等生物活性。

  • GC38620 structure
    GC38620Dihydrorotenone
    CAS: 6659-45-6
    纯度: >98.00%

    Dihydrorotenone是一种杀虫剂,是线粒体复合物I的不可逆抑制剂,并且能够穿过血脑屏障。

  • GC38653 structure
    GC38653Selumetinib sulfate
    CAS: 943332-08-9
    纯度: >99.00%

    Selumetinib (AZD6244) 是一种高效选择性的,非 ATP 竞争性的 MEK1/2 抑制剂, 抑制 MEK1 的 IC50 为 14 nM。Selumetinib (AZD6244) 抑制 MEK1/2 磷酸化水平。

  • GC38683 structure
    GC38683Benzyl isothiocyanate
    CAS: 622-78-6
    纯度: >98.00%

    Benzyl isothiocyanate (BITC, Benzoylthiocarbimide, Isothiocyanic Acid Benzoyl Ester) is an isothiocyanate originally found in cruciferous vegetables that exhibits immunomodulatory, anti-parasitic, antibiotic, antioxidative, anti-atherosclerotic, anti-angiogenic, anti-metastatic, anticancer chemotherapeutic, and chemopreventive activities.

  • GC38710 structure
    GC38710TVB-3166
    CAS: 1533438-83-3
    纯度: >99.50%

    A FASN inhibitor

  • GC38740 structure
    GC38740BMS-1001 hydrochloride
    CAS: 2113650-04-5
    纯度: >98.00%

    An inhibitor of the PD-1/PD-L1 interaction

  • GC38772 structure
    GC38772DIM-C-pPhOH
    CAS: 151358-47-3
    纯度: >98.00%

    DIM-C-pPhOH是一种核受体4A1(NR4A1)拮抗剂,可引起细胞凋亡和细胞应激。

  • GC38811 structure
    GC38811Mcl1-IN-8
    CAS: 678158-55-9
    纯度: >98.00%

    Mcl1-IN-8 (Compound 8) 是一种具有口服活性的 Mcl-1-PUMA 界面抑制剂,Ki 为 0.3 μM. Mcl1-IN-8 在减少 PUMA 依赖性细胞凋亡方面表现出双重活性,同时在癌细胞中失活 Mcl-1 介导的抗细胞凋亡。

  • GC38812 structure
    GC38812MD-224
    CAS: 2136247-12-4
    纯度: >98.00% / >99.00%

    MD-224 是一种作用强大的MDM2蛋白降解剂,由Cereblon和MDM2配体组成,能够促使MDM2蛋白迅速降解。

  • GC38817 structure
    GC38817Minerval
    CAS: 56472-29-8
    纯度: >98.00%

    A synthetic monounsaturated hydroxylated fatty acid

  • GC38819 structure
    GC38819ML334
    CAS: 1432500-66-7
    纯度: >99.50% / >98.00%

    ML334是一种有效的NRF2细胞渗透性激活剂。

  • GC38841 structure
    GC38841RIPK1-IN-4
    CAS: 1481641-08-0
    纯度: >98.00%

    RIPK1-IN-4 (compound 8) 是一种有效的 II 型激酶受体相互作用蛋白1 (RIP1) 激酶抑制剂,并且与 DL1-out 无活性形式的 RIP1 结合,对于 RIP1 和 ADP-Glo 激酶,IC50 为分别为 16 nM 和 10 nM。

  • GC38848 structure
    GC38848Se-Methylselenocysteine
    CAS: 26046-90-2
    纯度: >98.00%

    A selenium-containing amino acid

  • GC38853 structure
    GC38853Tandutinib hydrochloride
    CAS: 2438900-70-8
    纯度: >98.50%

    An antagonist of PDGFRβ, FLT3, and c- Kit

  • GC38863 structure
    GC38863TK216
    CAS: 1903783-48-1
    纯度: >99.50%

    TK216 is a potent inhibitor targeting E26 transformation specific (ETS) factors via blocking the protein-protein interaction with RNA helicases. TK216 exhibits antilymphoma activity.

  • GC38864 structure
    GC38864TL02-59
    CAS: 1315330-17-6
    纯度: >99.50%

    TL02-59 is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM.